期刊文献+

Chemerin与动脉粥样硬化的关系 被引量:6

Relationship between chemerin and atherosclerosis
原文传递
导出
摘要 新发现的脂肪细胞因子chemerin不仅是传统意义上的趋化蛋白,还通过多种途径参与动脉粥样硬化的发展。其可能机制是参与胰岛素抵抗,糖、脂代谢异常及代谢综合征的发生,进而促进动脉粥样硬化的发展;直接影响血管内皮细胞的炎性反应状态,促进单核巨噬细胞黏附、迁移以及泡沫细胞的形成;促进新生血管形成,使斑块不稳定性增加,参与斑块破裂、血栓形成。深入研究chemerin与动脉粥样硬化的关系将为动脉粥样硬化的防治提供新靶点。 The newly discovered adipokine chemefin not only is a chemoattractant, but also partici- pates in the development of atheroselerosis. Its possible mechanisms are that chemerin plays a role in insulin resistance, glucose and lipid metabolism dysfunction and metabolic syndrome, thus contributes to the develop- ment of atherosclerosis ; directly affects the inflammatory stale of vascular endothelial cells, promotes mono- cytes/macrophages to migrate and adhere to endothelial cells and the formation of foam cells ; promotes angio- genesis and increases plaque instability, involving in plaque rupture and thrombosis. Therefore, study the rela- tionship between chemerin and atheroselerosis thoroughly will provide a new target for prevention and treat- ment of atherosclerosis.
作者 袁仙仙 陶红
出处 《国际内分泌代谢杂志》 北大核心 2013年第3期195-198,共4页 International Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目(81100600)
关键词 动脉粥样硬化 CHEMERIN 代谢综合征 血管旁脂肪组织 斑块 Atherosclerosis Chemerin Metabolic syndrome Perivascular adipose tissue Plaque
  • 相关文献

参考文献4

二级参考文献74

  • 1陈韵岱.冠状动脉易损斑块的识别[J].心肺血管病杂志,2010,29(S1):7-9. 被引量:6
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5227
  • 3Delgado MB, Clark-Lewis I, Loetscher P, Langen H, Thelen M, Baggiolini M and Wolf M. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur J immunol 2001, 31: 699-707.
  • 4Davis DA, Singer KE, De La Luz Sierra M, Narazaki M, Yang F, Fales HM and Yarchoan R, et al. Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-lalpha in the circulation. Blood 2005, 105:4561 4568.
  • 5De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R and Zhang HH, et al. Differential processing of stromalderived factor-lalpha and stromal-derived factor-lbeta explains functional diversity. Blood 2004, 103:2452 -2459.
  • 6Wittamer V, Gregoire F, Robberecht P, Vassart G, Communi D and Parmentier M. The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J Biol Chem 2004, 279:9956 9962.
  • 7Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J and Hendrick AG, et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008, 205:767- 775.
  • 8Wittamer V, Bondue B, Guillabert A, Vassart G, Parmentier M and Communi D. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J Immunol 2005, 175: 487- 493.
  • 9Myles T, Nishimura T, Yun TH, Nagashima M, Morser J, Patterson AJ and Pearl RG, et al. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. J Biol Chem 2003, 278: 51059-51067.
  • 10Kulig P, Zabel BA, Dubin G, Allen S J, Ohyama T, Potempa J and Handel TM, et al. Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin. J lmmtmol 2007, 178:3713 3720.

共引文献46

同被引文献44

  • 1TANG Fei1,2,DU Qiumei1,2 & LIU Yong-Jun3 1 Center for Infection and Immunity,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China,2 Graduate University of Chinese Academy of Sciences,Beijing 100049,China,3 Department of Immunology and Center for Cancer Immunology Research,University of Texas,M.D.Anderson Cancer Center,Houston,Texas 77030,USA.Plasmacytoid dendritic cells in antiviral immunity and autoimmunity[J].Science China(Life Sciences),2010,53(2):172-182. 被引量:23
  • 2胡剑麟,陈斌.勃起功能障碍与血管内皮功能关系的研究进展[J].中华男科学杂志,2007,13(7):632-635. 被引量:27
  • 3Ernst MC,Sinal CJ.Chemerin:at the crossroads of inflammation and obesity[J].Trends Endocrinol Metab,2010,21(11):660-667.
  • 4Aronis KN,Sahin Efe A,Chamberland JP,et al .Chemerin levelsas predictor of acute coronary events:a case control studynested within the veterans affairs normative aging study[J].Metabolism,2014,63(6):760-766.
  • 5Baokang D,Weihua J,Yanjun Z.Elevated serum chemerin levelsare associated with the presence of coronary artery disease inpatients with metabolic syndrome [J]. Intern Med J,2011,50:1093- 1097.
  • 6Reiner Z,Catapano AL,De Backer G,et al .ESC/EAS Guidelinesforthe management of dyslipidaemias:the Task Force forthe management of dyslipidaemias of the European Society ofCardiology (ESC)and the European Atherosclerosis Society(EAS)[J].Eur Heart J,2011,32:1769- 1818.
  • 7Spiroglou SG,Kostopoulos CG,Varakis JN,et al .Adipokines inperiaortic and epicardial adipose tissue:differential expressionand relation to atherosclerosis[J].J Atheroscler Thromb,2010,17:115- 130.
  • 8McCarthy TC,Zuniga LA,Zabel BA,et al .The novel adipokinechemerin significantly increases cholesterol uptake in humanmacrophages[J].FASEB J,2008,22:948.
  • 9Du XY,Zabel BA,Myles T,et al .Regulation of chemerin bioactivitybyplasma carboxypeptidase N ,carboxypeptidase B(activatedthrombin activable fibrinolysis inhibitor),and platelets[J].JBiol Chem,2009,284(2):751 -758.
  • 10Sawayama Y,Maeda S,Ohnishi H,et al .Effect of probucol onelderly hypercholesterolemic patients in the FAST study [J].Fukuoka Iqaku Zasshi,2006,97(1):15 -24.

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部